Cargando…
Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer Lacking Driver Mutations and Future Perspectives
SIMPLE SUMMARY: The following paper was developed as a reference for healthcare workers who are looking for information on advanced non-small cell lung cancers that lack driver mutations and their treatment with immunotherapy. The aim of the present study is to provide a reliable data source based o...
Autores principales: | De Mello, Ramon Andrade Bezerra, Voscaboinik, Rafael, Luciano, João Vittor Pires, Cremonese, Rafaela Vilela, Amaral, Giovanna Araujo, Castelo-Branco, Pedro, Antoniou, Georgios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749892/ https://www.ncbi.nlm.nih.gov/pubmed/35008287 http://dx.doi.org/10.3390/cancers14010122 |
Ejemplares similares
-
The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer
por: De Mello, Ramon Andrade, et al.
Publicado: (2020) -
New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives
por: de Mello, Ramon Andrade, et al.
Publicado: (2020) -
Potential role of immunotherapy in advanced non-small-cell lung cancer
por: de Mello, Ramon Andrade, et al.
Publicado: (2016) -
Biomarkers for Non-Small Cell Lung Cancer: From the Bench to the Bedside
por: de Mello, Ramon Andrade, et al.
Publicado: (2020) -
CRISPR-based strategies in infectious disease diagnosis and therapy
por: Binnie, Alexandra, et al.
Publicado: (2021)